Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
0.4151
-0.0135 (-3.15%)
At close: Apr 16, 2026, 4:00 PM EDT
0.409739
-0.0054 (-1.29%)
After-hours: Apr 16, 2026, 7:59 PM EDT

Jaguar Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11.5111.699.7611.964.34
Revenue Growth (YoY)
-1.52%19.75%-18.36%175.80%-53.81%
Cost of Revenue
3.771.962.042.022.33
Gross Profit
7.749.737.729.942
Selling, General & Admin
27.8824.0223.0526.7126
Research & Development
24.9716.5418.617.6515.08
Other Operating Expenses
0.8-0.37-1.63
Total Operating Expenses
53.6540.5742.0244.3542.71
Operating Income
-45.91-30.83-34.29-34.42-40.71
Interest Expense
---6.38-12.72-8.42
Other Non-Operating Income (Expense)
-8.09-8.42-1.23-1.26-3.47
Total Non-Operating Income (Expense)
-8.09-8.42-7.61-13.98-11.89
Pretax Income
-54-39.25-41.9-48.4-52.6
Net Income
-53.58-38.49-41.3-47.45-52.6
Minority Interest in Earnings
-0.56-0.76-0.6-0.94-0.01
Net Income Attributable to Preferred Dividends
-0.14----
Net Income to Common
-53.58-38.49-41.3-47.45-52.6
Shares Outstanding (Basic)
20000
Shares Outstanding (Diluted)
20000
Shares Change (YoY)
691.89%1809.95%1663.72%119.99%247.08%
EPS (Basic)
-22.97-130.69-2678.17-54270.00-132330.00
EPS (Diluted)
-22.97-130.69-2678.17-54270.00-132330.00
Shares Outstanding
6.980.530.0500
Free Cash Flow
-23.73-29.4-33.26-33.18-34.38
Free Cash Flow Per Share
-10.17-99.82-2156.67-37949.50-86490.70
Gross Margin
67.21%83.27%79.13%83.11%46.18%
Operating Margin
-398.82%-263.76%-351.31%-287.85%-939.05%
Profit Margin
-469.09%-335.79%-429.27%-404.78%-1213.38%
FCF Margin
-206.12%-251.52%-340.72%-277.53%-792.99%
EBITDA
-44-28.93-32.28-32.43-38.99
EBITDA Margin
-382.20%-247.51%-330.68%-271.28%-899.40%
EBIT
-45.91-30.83-34.29-34.42-40.71
EBIT Margin
-398.82%-263.76%-351.31%-287.85%-939.05%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q